|
With the 2009 edition, the American Hospital Formulary Service® (AHFS™) marks over 50 years of continuous publication by the American Society of Health-System Pharmacists (ASHP). Each year, an average of over 60% of AHFS content is revised to help you provide the most accurate recommendations for your patients’ drug therapy.
AHFS references are evidence-based and peer-reviewed, compiled without the influence of manufacturers, insurers, regulators or other interested parties. No other drug information sources can make this claim.
AHFS DI has been designated as an official compendium by the US Congress.
AHFS DI contains information from medical literature and expert advice from over 500 medical scientists, physicians, pharmacists, pharmacologists and other professionally qualified individuals that goes beyond FDA-approved labeling.
Find inside:
- Expanded and revised content for 2009, including many new monographs
- Extensive off-label uses.
- Expert advice and peer reviewed by over 500 medical scientists, physicians,
pharmacists, pharmacologists, and other professionally qualified individuals
- Over 40,000 represented medicines and over 100,000 drug products
- Over 70,000 uniquely cited references
- Only well-established, referenced laboratory test interferences
- Monographs include: drug interactions; adverse reactions; cautions and toxicity; therapeutic perspective; specific dosage and administration information; preparations, chemistry, and stability; pharmacology and pharmacokinetics; contraindications; and more.
Over 700 monographs were revised for inclusion in the 2009 print edition of AHFS Drug Information. These revisions incorporate new or updated therapeutic guidelines from:
- the American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines on Antithrombotic and Thrombolytic Therapy;
- US Department of Health and Human Services (HHS) guidelines for the management of HIV infection in adults and children and guidelines for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission;
- multiple guidelines regarding screening and treating pediatric patients for lipid disorders from the National Cholesterol Education Program (NCEP), the American Academy of Pediatrics (AAP), and the American Heart Association (AHA) among others;
- recommendations for prevention and treatment of opportunistic infections in HIV-infected individuals approved by Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and the HIV Medicine Association of the Infectious Diseases Society of America (IDSA);
- Centers for Disease Control and Prevention (CDC) for influenza vaccination and management; the latest (January 2009) US Recommended Immunization Schedules for Children and Adolescents, which was issued by the CDC, AAP, and American Academy of Family Physicians (AAFP), as well as the revised (January 2009) US Recommended Immunization Schedules for Adults that incorporates the recommendations of CDC, AAFP, American College of Physicians (ACP), and ACOG;
- US Centers for Disease Control and Prevention (CDC) health information for international
travel;
- AHA and AAP regarding the need for routine ECG screening in all pediatric patients being considered for or currently receiving stimulant therapy.
Dozens of other monographs were revised based on FDA MedWatch notices.
This title updates: Monthly
|
